Peer-reviewedCC BY 4.0Frontiers in Immunology
Editorial: Liver diseases – from pathophysiology to new treatment options
4 affiliations
- 1Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens
- 2Division of Cardiology, Pulmonology, and Vascular Medicine, University Hospital and Medical Faculty, Heinrich Heine University
- 3Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens
- 4Fourth Department of Internal Medicine, “Attikon” University Hospital, School of Medicine, National and Kapodistrian University of Athens
Related
- Editorial: Herbal medicine for the treatment of chronic metabolic diseases, volume II
- Editorial: Roles of metabolism, immunity, and microbiome in the pathophysiology of the breast cancer microenvironment
- Editorial: Chronic large-vessel occlusion in cerebrovascular disease: pathophysiology, diagnosis, and therapeutic advances
- Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies.
- Stellate ganglion block for ventricular arrhythmia disease states: Emerging treatment options
BibTeX
@article{androutsakos2026editorial,
title = {{Editorial: Liver diseases – from pathophysiology to new treatment options}},
author = {Theodoros Androutsakos and Narjes Nasiri-Ansari and Margarita Papatheodoridi and Dimitrios Karagiannakis},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.2020350},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2020350/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Liver diseases – from pathophysiology to new treatment options
AU - Theodoros Androutsakos
AU - Narjes Nasiri-Ansari
AU - Margarita Papatheodoridi
AU - Dimitrios Karagiannakis
PY - 2026
DA - 2026/10/20
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.2020350
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2020350/full
SN - 1664-3224
ER -